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 In the late 20th century there was very little focus on low vitamin D levels as a 
health concern.  With the introduction of vitamin D fortified milk and food products in 
the 1950’s, medical clinicians believed that vitamin D deficiency was no longer a health 
concern. However, after the turn of the century research examining vitamin D levels in 
adults demonstrating that a large portion of the United States population was vitamin D 
deficiency.  This discovery lead to hundreds of studies in the last decade which aim to 
figure out the role of vitamin D in overall health and determine what clinical 
consequences occur in a deficient state.  Vitamin D deficiency has now been associated 
with many acute and chronic conditions.  
Specifically, the first manuscript in this capstone report focuses on the connection 
between Vitamin D deficiency and Type 2 Diabetes (DM2). Although a cause and effect 
relationship between vitamin D deficiency and increased risk of DM2 is still elusive, 
many studies have demonstrated an association between the two chronic disease states.  
A Literature Review from 2009 examining 12 articles demonstrated that patients who are 
diabetic are more likely than the general population to have vitamin D deficiency.  
Additionally, individuals who were deficient in vitamin D are more likely to get DM2 
and to get the disease at an earlier age.  Finally, diabetics who are concurrently vitamin D 
deficient have poorer control of sugar levels.  This research indicates that vitamin D 
deficiency may play a role in the development and treatment of DM2, however, more 
research is needed to examine that role.   
The second manuscript in this capstone reviews the current clinical knowledge 
regarding vitamin D deficiency.  This article begins with the definition of vitamin D 
insufficiency and deficiency and its correlation to chronic disease states.  Next, the risk 
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factors and epidemiology of vitamin D deficiency are discussed. Finally the article 
summarizes the latest information on appropriate clinical screening and treatment of 
vitamin D deficiency.   
The third manuscript in this capstone series details a research study completed in 
2012 to determine the knowledge level of nurse practitioners regarding vitamin D 
deficiency.  A survey was distributed to nurse practitioners at a national conference.  The 
results indicate that nurse practitioners overall have poor knowledge of vitamin D 
deficiency.  Nurse practitioners are expected to make critical decisions regarding patient 
care and it is important that they have a good understanding of vitamin D deficiency 
ensuring that they can appropriately treat patients.  The results of this study indicate that 
more education is needed regarding vitamin D deficiency and its connection with chronic 
disease.   
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A Systematic Review  
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Abstract 
Purpose: Type 2 Diabetes Mellitus (DM2) is a leading cause of morbidity and mortality 
and  vitamin D deficiency may promote poor glucose metabolism. This systematic review 
examines the relationship between vitamin D deficiency and DM2. 
Data Sources: An electronic search of articles published from 2005 to 2012 in CINAHL, 
PubMed, Medline, EBSCO, Cochrane Library, EMBASE, and Pascal was performed.    
Conclusion: Cohort studies show a relationship between low vitamin D status and 
prevalence of DM2. Inverse correlations exist between low vitamin D status and β-cell 
insulin secretion, insulin resistance, and fasting plasma glucose levels. Studies are limited 
because of the cross-sectional design, poor follow-up, and lack of adjustments for 
confounders. Two intervention studies show mixed results, but they include sub-
therapeutic doses of vitamin D and small sample sizes. Case studies demonstrated a 12% 
decrease in sugar levels. The current evidence suggests that vitamin D does play a role in 
effective glucose metabolism; however, more controlled intervention trials are needed to 
fully explain this relationship.  
Implications for Practice: Screening and treatment of vitamin D deficiency could help 
in the prevention or treatment of DM2. Screening and treatment can prevent 
complications and improve quality of life in a cost effective manner. 
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The Association between Vitamin D Deficiency and Type 2 Diabetes: A Systematic 
Review 
Background 
The incidence of type 2 diabetes mellitus (DM2) is increasing at a disturbing rate 
in the United States. According to the Centers for Disease Control (CDC), the prevalence 
of DM2 is estimated at 25.8 million people or 8.3% of the population (Center for Disease 
Control, 2011).  Diabetes is the 7th leading cause of death, and also contributes to the 
development of heart disease, stroke, high blood pressure, neuropathy, blindness, and 
kidney disease.  The CDC estimates the costs of diabetes and its associated morbidities to 
be $174 billion but the immeasurable cost is in the loss of quality of life and the 
premature death that commonly occur with the disease.  DM2 is a result of genetics and 
lifestyle factors such as diet and exercise but is primarily associated with obesity 
(Chagas, Borges, Martini, & Rogero, 2012).  Given that weight loss is difficult to achieve 
and maintain it is essential that other potentially modifiable risk factors for type 2 
diabetes be examined.  One potential risk factor that is currently being investigated is the 
occurrence of sub-optimal serum vitamin D levels. The purpose of this article is to 
systematically review the association between vitamin D and type 2 diabetes mellitus, 
and explore the possibility that enhancement of serum vitamin D to a prescribed level, 
may augment current diabetes treatment and prevention strategies.  
 Vitamin D is a fat soluble vitamin which is dependent on consumption from foods 
that are naturally rich in the vitamin or fortified such as fish, eggs, and milk.  
Additionally, vitamin D can be synthesized under ultra-violet (UV) exposure in the skin 
(Bohaty, Rocole, Wehling, & Waltman, 2008).  Both methods provide the body with a 
precursor vitamin that is converted to the active form of vitamin D via the liver and the 
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kidney. Once it appeared that rickets (associated with a lack of vitamin D) was a disease 
of the past, many health providers did not give much recognition to vitamin D or the 
implications of vitamin D deficiency. However, recently studies started emerging that 
demonstrate large portions of the population suffers from hypovitaminosis D (Holick, 
2007).  A large cross-sectional cohort study that analyzed data from the National Health 
and Nutrition Examination Survey (NHANES III) determined that 50.73% of all women 
tested were deficient in vitamin D.  This number increased to 72.46% when examining 
Hispanic women (Zadshir, Tareen, Pan, Norris, & Martins, 2005). A second study by 
Yetley examined data from the National Nutrition Monitoring System which determined 
a 30% prevalence of vitamin D deficiency at the current standard and a 70% deficiency 
when analyzed against a proposed higher standard vitamin D level (2008). Additionally, 
females were more likely to have a greater deficiency then males in all ages except 
children ages 1-5. Yetley also found that vitamin D levels have an inverse relationship to 
body mass index (BMI). Furthermore, it appears that vitamin D deficiency can occur 
even in people that live in sunny climates and are consistently exposed to the sun’s UV 
rays.  A study performed in Arizona found that even with a history of adequate sun 
exposure, deficiency occurred in 25% of the population studied (Jacobs et al., 2008).  
This study also provided data that reinforced increased prevalence in women, Hispanics, 
Blacks, and obese individuals.       
The most well-known function of vitamin D is to maintain calcium and 
phosphorus homeostasis; however, the discovery that most cells on the body have a 
vitamin D receptor suggests that the vitamin could have many more functions within the 
body (Holick, 2012).   Sub-optimal vitamin D is associated with multiple musculoskeletal 
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disorders including osteoporosis and osteoporosis related fractures, muscle pain, 
weakness, and increased risk of falls (Binkley, 2012; Haroon & FitzGerald, 2012).  
Additionally, vitamin D deficiency has been linked to several different forms of cancer 
including colon, prostate and breast cancer (Mitchell, 2011).  It has even been suggested 
that vitamin D can also have an influence on common age-related morbidities including 
dysphagia, urinary incontinence, and cognitive decline (Binkley, 2007).  More recently, 
evidence suggests that sub-optimal serum vitamin D levels may play a role in the 
development of DM2.  Evidence indicates that vitamin D may have a direct role in 
insulin secretion and the utilization of insulin by peripheral tissue.  It is hypothesized that 
binding of circulating 1,25-dihydroxyvitamin D (the active form of vitamin D) to the 
pancreatic β-cell vitamin D receptor promotes insulin secretion (Peechakara & Pittas, 
2008).  Additionally, the regulation of calcium levels by vitamin D can also indirectly 
promote β-cell insulin secretion by maintaining a consistent flux of calcium into the cell.  
Finally, it also appears that vitamin D stimulates the expression of insulin receptors on 
target-tissues which facilitates the uptake and use of insulin (Penckofer, Kouba, Wallis, 
& Emanuele, 2008).   
Methods 
An electronic search was conducted to identify studies that were published from 
2005 to 2012 in the following databases: CINAHL, PubMed, Medline, EBSCO, 
Cochrane Library, EMBASE, and Pascal.   Articles were limited to English language.  
Focus was placed on cohort and case control studies, as well as randomized controlled 
trials (RCT) that examined the relationship between vitamin D deficiency and DM2.  
Because metabolic syndrome has the same risk factors as DM2 and is a known precursor, 
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data examining the link between vitamin D and metabolic syndrome were also 
investigated.  Keywords used were: type 2 diabetes, DM2, metabolic syndrome, vitamin 
D deficiency, hypovitaminosis D, β-cell function, and insulin resistance. Nine articles 
were retrieved via the electronic search method.  An additional three articles were found 
while reviewing the references to those articles and other literature reviews on the topic.  
The total number of articles reviewed was 12.  
Inclusion/Exclusion Criteria 
For inclusion to the systematic review, articles needed to focus on the relationship 
between vitamin D and DM2 or metabolic syndrome.  Because there were relatively few 
randomized controlled trials, well designed cohort and case control studies were also 
reviewed. Because there are so few studies that have examined the relationship between 
vitamin D deficiency and DM2, all levels of evidence were included in the review. 
Studies were critiqued by the Center for Evidence Based Medicine’s evidenced based 
practice score.  Limitations to each study, especially those that are lower levels of 
evidence, are addressed in the results section.  Studies that examined DM2 in children 
and those that focused on type 1diabetes were excluded because of the variation of 
insulin metabolism in children and the varied pathology and cause of type 1 diabetes.  
Studies that examined vitamin D deficiency in relation to other chronic health problems 
such as renal disease, gastro-intestinal malabsorption syndromes, and parathyroid gland 
pathologies were also excluded.  Finally, studies where the primary subject focus was 
pregnant women or women who were breast feeding were also excluded due to the 
additional nutritional demands that occur in those unique physiologic states which could 
affect serum vitamin D levels, requirements, and intake.  
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Results 
 In 2004, Chiu et al. were the first to directly measure insulin secretion and insulin 
sensitivity and relate those to serum vitamin D levels. The results demonstrated that 
vitamin D levels had a negative correlation with fasting plasma glucose levels and a 
positive correlation with the insulin sensitivity index (ISI).  These associations remained 
after adjusting for age, sex, ethnicity, BMI, waist to hip ratio, systolic and diastolic blood 
pressure, and season (p < .0001). This important study indicated that vitamin D seems to 
be an independent factor in proper beta cell function and insulin sensitivity, two 
important factors in the development of DM2.  Since the release of that study there has 
been increased interest in the relationship between vitamin D levels and type DM2. 
 There are very few randomized controlled intervention trials examining the 
relationship between vitamin D and DM2.  Therefore, the bulk of the evidence on this 
relationship has been demonstrated through cohort studies. Of the cohort studies 
reviewed there were four cross-sectional studies, one retrospective study, and four 
prospective studies.  In all of the cohort studies one outcome that was consistent was that 
women had an increased prevalence of vitamin D deficiency over men.  When examining 
the relationship between vitamin D and DM2 the results are inconsistent.  
 In the largest cross-sectional study to date, 8,241 individuals (see table 1 for 
characteristics of cohort studies) from the National Health and Nutrition Examination 
Survey (NHANES), a random, national cohort, were examined to determine the 
relationship between their vitamin D level and risk of having metabolic syndrome (Ford, 
Ajani, McGuire, & Liu, 2005).  After adjusting for multiple confounders, vitamin D 
influenced risk of metabolic syndrome. The odds of having metabolic syndrome 
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decreased with each increasing quintile of vitamin D level (OR .85 - .38).  Another cross-
sectional study looked at a non-diabetic population from the Framingham Offspring 
Study (Liu et al., 2009).  The results were similar to the NHANES study suggesting that 
an increased vitamin D level is associated with decreased risk factors for DM2.  More 
specifically subjects in the higher tertile of vitamin D levels had a 1.6% lower fasting 
plasma glucose, 9.8% fasting insulin secretion, and a 12.7% lower insulin resistance 
score than subjects in the lowest tertile. This relationship remained after adjustments for 
confounding factors.     
In 2009, Wehr et al. also looked at the risk of metabolic syndrome based on 
vitamin D status in a population of women with polycystic ovary syndrome (PCOS).  
This study reinforced the data from the previous study that the odds of having metabolic 
syndrome increases with decreased vitamin D levels. Results suggested an inverse 
relationship between vitamin D levels and fasting and stimulated glucose levels, insulin 
resistance based on the homeostatic model assessment (HOMA-IR), insulin secretion 
based on the homeostatic model assessment (HOMA-β), and C-reactive protein (CRP).  
This study is limited by adjustments for only age, BMI, and season.  However, the 
consistency of the findings is still suggestive of a significant relationship between vitamin 
D and DM2.    
Only one cross-sectional cohort study found no significant relationship between 
vitamin D levels and DM2 (Snijder et al., 2006).  However, there are several limitations 
to the study.  One main limitation was that the only outcome measured was incidence of 
DM2 which may not be as sensitive as measuring direct physiologic changes in insulin 
secretion and uptake.  Additionally, the average age of the population studied was 75yo ± 
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6.5 years.  This homogenous elderly population is not a representative sample of the 
general population.   
There were four prospective cohort studies reviewed. In 2006, data from the 
Nurse’s Health study were reviewed (Pittas et al.).  Results stated that women who 
consumed >800 IU of vitamin D or more daily had 23% lower risk of DM2 compared 
with women who consumed  < 200 IU per day.  The risk ratio (RR) was .87; however, 
after adjustments for confounding variables the results were not significant (p = 0.67).  
Limitations of the study included a poor follow-up rate (5%) and an almost homogenous 
sample of Caucasian females.  In another study, data were examined from the 1958 
British Birth Cohort (Hypponen & Power, 2006).  All subjects were born in 1958 and 
were 45 years old at the time of data collection in 2003. Hemoglobin A1C (HbA1C) was 
measured as an outcome to this study.  Results demonstrated that increased vitamin D 
levels were associated with decreased HbA1C (p<0.0001).   
A prospective cohort study which looked at a random sample of men and women 
in Finland, demonstrated at the higher quartile of vitamin D level verses the lowest 
quartile an inverse relationship between vitamin D levels and risk of DM2 (RR=.70) 
(Mattila et al., 2007).  However, after adjustments for confounding variables the results 
did not remain significant at p =.07. Finally, a study of 524 non-diabetic men and women 
did demonstrate a significant relationship between vitamin D levels and diabetes 
associated factors (Forouhi, Luan, Cooper, Boucher, & Wareham, 2008).  Results 
indicated that increased levels of vitamin D were associated with a lower 10-year risk of 
hyperglycemia, lower insulin levels, and decreased insulin tissue resistance (HOMA-IR) 
independent of confounders.   
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In one retrospective study that was reviewed, a convenience sample of post-
menopausal women, was studied (Need, O'Loughlin, Horowitz, & Nordin, 2005).  The 
results suggested that vitamin D level influenced fasting glucose levels independent from 
age and BMI.  This relationship was strongest in women who had vitamin D levels that 
were by definition deficient or < 20ng/mL.  The authors inferred that since increased 
fasting glucose levels are a direct indicator of metabolic syndrome and DM2 by 
implication it was determined that vitamin D levels play a role in poor glucose 
metabolism.   
Of the cohort studies reviewed there were six that demonstrated a relationship 
between vitamin D levels and DM2 or one of the significant factors known to play a role 
in the development of diabetes.  Two studies initially demonstrated a significant 
relationship but significance did not remain after adjusting for confounding factors.  
Finally, one study did not show any relationship. Many of the cohort studies were 
plagued by poor follow-up, homogenous populations, and outcomes that are influenced 
by multiple factors.  These cohort studies suggest that future research on the topic of 
vitamin D deficiency is warranted.  
There are only two RTCs that examine the relationship of vitamin D and factors 
that can contribute to metabolic syndrome and DM2.  In one study, 314 Caucasian adults 
who did not have diabetes received either 500 mg of calcium citrate and 700 IU of 
vitamin D or placebos daily for three years (Pittas, Harris, Stark, & Dawson-Hughes, 
2007).  Participants were divided into two groups at baseline representing those with 
normal glucose metabolism and those with impaired fasting glucose (IFG) levels. The 
two groups were matched with controls for age, weight, and physical activity score.  
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There was a higher percentage of “never smokers” in both intervention groups 53% to 
42% in the normal glucose subgroup and 36% to 32% in the IFG subgroup. The study 
showed a significant increase in vitamin D levels in both of the intervention groups.  
There was no significant difference in fasting plasma glucose levels, CRP, interleukin-6 
levels, or incidence of DM2 between either of the intervention groups and their respective 
placebo groups. However, in the IFG subgroup insulin resistance measured by HOMA-IR 
increased significantly more in the placebo group than in the group that was taking 
vitamin D.   In the normal glucose group there was no difference in insulin resistance.   
This study demonstrated a greater effect of vitamin D on the impaired group.  Limitations 
to this study include a relatively small sample size, a homogenous sample, and the 
intervention included vitamin D and calcium supplementation rather than vitamin D 
alone. 
The second RCT was from the Women’s Health Initiative study.  In one arm of 
the study, randomly assigned postmenopausal women received 1000mg of elemental 
calcium and 400 IU of vitamin D daily while the control group received a placebo in a 
double-blinded fashion (de Boer et al., 2008).  After a mean follow-up time of seven 
years 2,291 women were diagnosed with diabetes.  The hazard ratio for incidence of 
diabetes between groups was 1.01 demonstrating a null result.  There have been several 
noted limitations to this study.  One major limitation was that there was no certainty that 
the control group did not take vitamin D either within a multivitamin or as a supplement.  
Because of the double-blinded fashion control subjects were not instructed to refrain from 
taking any supplemental vitamin D.  Additionally, the amount of vitamin D used in the 
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intervention (400 IU) is a small dose that does not tend to affect overall serum vitamin D 
levels.    
Evidence from the RCTs suggests that there is an association between vitamin D 
and insulin resistance; however, there was not an association between vitamin D and each 
of the other outcomes tested. Both RCTs have significant limitations and based on the 
results of the previous cohort studies more RCTs are needed to help determine the exact 
relationship between vitamin D and DM2.   
Finally, an article detailing two specific case studies was reviewed 
(Schwalfenberg, 2008).   One case study detailed a 63-year-old African American 
diabetic who had an unchanging A1C of 8.4% on oral medications diet and exercise.  
After it was determined her vitamin D level was severely deficient, she was started on 
vitamin D replacement therapy at 2000 IU for two months and then 3000 IU for nine 
months.  After taking vitamin D for 6 months her HbA1C was reduced to 7.4%.  The 
author also reported that the patient experienced a greater number of hypoglycemic 
episodes and consequently reduced her metformin dose from 500mg three times a day to 
twice daily.  Finally, the patient actually reported that she exercised less in the 6 months 
that she was on vitamin D therapy, but her weight remained stable and her diabetes 
improved.  The second case study examined a 71-year-old white female with long term 
diabetes treated with several oral medications.  With an A1C of 13.3%, it was 
recommended that she start insulin; however, the patient refused.  Around the same time 
her vitamin D deficiency was discovered.  After nine months of vitamin D repletion and 
no other change in her diabetic treatment regimen at 2000 IU per day, her HbA1C level 
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was reduced to 12.2%.  In both case studies the dependent variable of vitamin D repletion 
resulted in an average decrease in blood sugar levels of 12%.  
Optimal Intake of Vitamin D in Relation to Type 2 Diabetes 
According to Holick and Chen (2008), Vitamin D deficiency is currently defined 
as <20 ng/mL of serum 25-hydroxyvitamin D [25(OH)D] which is the major circulating 
form of vitamin D.   Levels <30 ng/mL 25(OH)D are considered insufficient.  The 
threshold of 30ng/mL was determined to be adequate because above those levels bone 
undergoes proper mineralization eliminating rickets.  However, the recent discovery of 
vitamin D receptors on almost every cell in the body including breast, prostate, muscle, 
pancreatic and immune cells has prompted researchers to reexamine the minimum 
acceptable level (Holick, 2007). Currently the Institute of Medicine (IOM) recommends 
that children and adults up to 50 years old should receive 400 IU of vitamin D daily and 
adults over age 70 need 600 IU, as well as 15 minutes of direct unprotected sunlight to 
the hands and face every day (Institute of Medicine, 2010).  These recommendations are 
based on the 30ng/mL threshold to prevent rickets.  According to Vieth et al. (2007) 
studies are suggesting that higher levels of vitamin D intake are necessary to prevent 
other pathologies associated with vitamin D including preventing cancer, reducing 
fractures and reducing risk of chronic diseases such as diabetes.  Specifically studies that 
have examined fracture prevention have demonstrated decreased risk of fracture with 
vitamin D levels up to 40ng/mL (Bischoff-Ferrari, Giovannucci, Willett, Dietrich, & 
Dawson-Hughes, 2006).  One recent study examined participants who were consistently 
exposed to a sun-rich environment and women who were on taking 6400 IU of vitamin 
D3 daily (Hollis, Wagner, Drezner, & Binkley, 2007).  In both the natural and 
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supplemented vitamin D groups levels peaked between 40 to 60ng/mL and additional 
sunlight or supplementation did not increase levels further.  This indicates that an optimal 
therapeutic range of vitamin D could be higher than the current standard.  As for optimal 
vitamin D levels and type 2 diabetes specifically, there is not enough data currently to 
suggest an optimal level; however, the current best evidence indicates that vitamin D 
levels of <20 ng/mL were associated with increased risk factors for metabolic syndrome 
and DM2.  Future research should evaluate serum vitamin D levels of 40 - 60ng/mL to 
determine if higher serum levels result in better patient outcomes.  
When examining the current evidence, particularly the RCTs, it is important to 
understand the amount of vitamin repletion necessary to make a meaningful impact on 
vitamin D levels.  For example the small dose (400 IU) given to women in the Women’s 
Health Initiative Study has only been shown to increase blood levels of vitamin D by 4 
ng/mL over a six month period of time (Heaney, Davies, Chen, Holick, & Barger-Lux, 
2003).  Vitamin D dosed at this level is sub-therapeutic, especially in a deficiency state, 
and would not be expected to produce meaningful outcomes. A recent study that 
addressed prescribing regimens for vitamin D repletion found that >600,000 IU of 
Vitamin D2 supplementation given for a mean of 60 days was necessary to achieve 
sufficiency in 64% of cases. There were no reports of vitamin D toxicity (Pepper, Judd, 
Nanes, & Tangpricha, 2009).  Experts suggest that in future intervention trials a 
substantial dose of 2000 IU per day is needed to raise vitamin D to optimal levels to truly 
explore its role in the prevention or attenuation of DM2 (Vieth et al., 2007).  
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Gaps and Future Research 
 Currently there are several gaps in the research regarding vitamin D deficiency 
and the presence of DM2.  The most obvious gap is the lack of well-constructed 
intervention trials with controls.  These trials need to have larger sample sizes and 
provide a vitamin D dose that is high enough to increase serum vitamin D levels above  
40ng/mL. Additional cohort studies are also needed to confirm the effect of vitamin D 
repletion on the two direct pathologies in DM2: β-cell insulin secretion and peripheral 
uptake of insulin.   These well controlled studies are also necessary to determine if 
vitamin D is truly a contributing factor to the development of DM2 or merely a marker 
for overall poor health.    
 Additionally, further research is needed to determine if the effects of vitamin D 
repletion occur across ethnic populations. The prevalence of vitamin D deficiency is 
highest in darker skinned individuals including black and Hispanic populations.  Studies 
that look at genetic polymorphisms or variation can help determine why there is ethnic 
variation in the processing of vitamin D from sunlight and help determine risk. These 
populations are known to be at the highest risk for diabetes.  Both intervention and cohort 
studies are needed to determine the effects of vitamin D in the prevention or in the 
treatment of DM2 in those special populations. 
 Finally, more research is needed to determine the best repletion practices as well 
as the optimal serum level of vitamin D.  Many experts believe that the current standard 
of 30ng/mL is too low; however, there is currently not enough research to establish a 
different standard.  Suggestions for optimal levels range for 40ng/mL to 80ng/mL.  With 
concentrated repletion regimens (> 600,000 IU) that lasted a mean of two months, only 
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64% of cases achieved sufficient values greater than 30ng/mL.  Additional research could 
determine a more consistent time frame and daily or weekly regimen to increase the 
success rates of vitamin D repletion.   
Conclusion 
Most diets in the United States do not provide sufficient vitamin D intake to 
maintain adequate serum levels.  In addition to poor intake, decreased sun exposure, 
increased use of sunscreen and genetic variations in the conversion of the sun’s UV rays 
to vitamin D are all causes of vitamin D deficiency.   Providers need to be aware that 
women, individuals with darker skin pigmentation, and those who are obese are at higher 
risk for vitamin D deficiency.  Vitamin D deficiency has been associated with many 
chronic conditions including DM2.  Specifically the evidence suggests that vitamin D 
influences β-cells secretion of insulin and ameliorates insulin resistance.  The outcome of 
these effects is an inverse relationship between vitamin D and HbA1C, fasting plasma 
glucose levels and incidence of metabolic syndrome. The possibility that a relatively 
inexpensive vitamin can help delay onset or assist with the treatment of DM2 has a 
number of public health implications.  Clinicians should consider testing high-risk 
individuals for vitamin D deficiency and supplement deficient patients, especially those 
with DM2.  Further research is necessary to determine the true impact of this cost-
effective and widely available intervention.   
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Table 1 
General characteristics of cohort studies relating DM2 and vitamin D                  
First Author/Yr Cohort Outcome 
Measure 
Results Adjustments 
for 
confounding 
factors 
Comments 
Wehr et al. (2009) 
(cross – sectional) 
Females with 
PCOS 
Mean age: 29   
n=206  
1 and 2 hr gtt; 
HOMA – IR1; 
HOMA – β2 
QUICKI3; CRP4 
- Vit. D prevalence = 72.8% 
- Inverse correlation b/t vit. D and 
fasting and stimulate glucose levels, 
HOMA-IR, HOMA- β and fasting 
and stimulated insulin, and CRP 
Season, BMI, 
and age 
No control group;  
low vitamin D 
levels are associated 
with features of 
metabolic syndrome 
Forouhi et al.  
(2008) 
(prospective) 
Random non-
diabetic men 
and women 
ages 40-69yo         
n=524 
2 hr gtt; insulin; 
metabolic 
syndrome risk z 
score; HOMA-
IR; 
- Women lower vit. D than men 
- Vitamin D inversely associated with 
10- year risk of hyperglycemia, 2h-
gtt, HOMA-IR, and metabolic 
syndrome risk   
Age, sex, 
smoking, 
BMI, season 
and baseline 
metabolic 
variable 
Higher vit. D is 
assoc. with lower 
future glucose, 
insulin, and 
HOMA-IR.  
Independent of 
confounders 
Liu et al.  (2008) 
(cross-sectional) 
Non-diabetics 
from 
Framingham 
Offspring 
Study 
n=808 
2 hr ggt; 
insulin, 
HOMA-IR; 
ISI5; plasma 
adiponectin  
-vitamin D inversely associated with 
waist circumference and BMI 
-positively associated with ISI, 
adiponectin and HDL 
-higher tertile of vit D had 1.6% 
lower fasting glucose; 9.8% lower 
fasting insulin; 12.7% lower insulin 
resistance score 
Age, sex, 
BMI, waist 
circumfe-
rence, 
smoking 
status 
Positive assoc. not 
significant after 
adjustments; vit D 
and 2 hr gtt was not 
significant; vit. D 
associated with 
increase in DM2 
risk markers even in 
nondiabetics 
Matilla et al.  (2007) 
(Prospective) 
random men 
and women 
from Finland 
n=4,079 
Incidence of 
DM2 
-inverse association of vit. D levels 
and risk of DM2 
-RR 0.60 (p=0.01) between highest 
quartile vitamin D and lowest 
-further adjustment attenuated to RR 
Age, sex, 
season then 
also BMI, 
exercise, 
smoking, 
Decreased RR of 
DM2 with higher 
serum levels of 
vitamin D although 
relationship is 
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= .70 (p=.07) education attenuated after 
confounding 
Hypponon et al.  
(2007) 
(Prospective) 
 
Random men 
and women in 
England all 
45 yo       
n = 7,198 
HbA1C6 -HbAIC decreased with increased vit. 
D levels up to 30ng/mL 
- HbA1C in deficient vit. D group – 
5.4%; sufficient group 5.1% 
sex, season, 
geography, 
exercise and 
social class 
Association was 
greater in obese 
subjects 
Pittas et al.  (2006) 
(Prospective) 
Random 
women from 
the nurse’s 
health study 
with 20 year 
f/u 
n=83,779/484
3 
Incidence of 
DM2 
-women who consumed > 800 IU or 
more of daily vitamin D intake had 
23% less lower risk of DM2 
compared with women who 
consumed <200 qd 
with RR .87 (p=.67) 
Age, BMI, 
exercise, 
family 
history DM2, 
smoking, 
ETOH, 
coffee, diet, 
HTN, 
calcium 
intake 
No history of 
diabetes, CVD, or 
cancer at baseline 
Risk decreased 
further when vit. D 
intake combined 
with increased 
calcium intake 
Non-significant p-
value 
Snijder et al.  (2005) 
(cross-sectional) 
Men and 
women from 
Amsterdam 
n=1,235 
Incidence of 
DM2 
-no significant association in 
incidence of DM2 and vitamin D 
levels   
Age, sex, 
waist to hip 
ratio, 
exercise, 
smoking, 
ETOH, 
season 
Mean age of 
participants was 
75yo ± 6.5 years 
which may have 
influenced results 
Need et al.  (2005) 
(retrospective) 
Convenience 
sample of 
post- 
menopausal 
Females   
n=753 
Fasting plasma 
glucose 
-Vitamin D inversely related to 
fasting glucose level. (p<.001) 
-Greatest increase was in those with a 
vit. D < 16ng/mL 
Age, BM Fasting serum 
glucose increased as 
vit. D levels 
decreased 
Ford et al.  (2005) 
(cross-sectional) 
Males and 
females from 
NHANES III 
Incidence of 
DM2 and 
fasting plasma 
The odds of having metabolic 
syndrome decreased with each 
increasing quintile of vitamin D level.  
Age, sex, 
race, 
exercise, 
Vitamin D still 
seemed to influence 
risk of DM2 even 
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N=8,241 glucose level OR .85 - .38 ETOH, 
smoking, 
diet, vitamin 
use, 
cholesterol, 
CRP, 
education, 
season 
after adjusting for 
confounders 
 
 
1.HOMA-IR: Homeostatic model assessment – Insulin Resistance 2. HOMA-β: Homeostatic model Assessment – β-cell 
secretion 3. QUICKI: Quantitative insulin sensitivity check index 4. CRP: C-reactive protein 5. ISI: Insulin sensitivity index 
6.HbAIC: Hemoglobin A1C 
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Abstract 
Purpose: To provide an update on vitamin D for nurse practitioners.  Media Reports and 
conflicting information result in confusion regarding the screening, diagnosis and 
management of vitamin D.  The physiology of vitamin D, definitions of vitamin D 
deficiency, risk factors for deficiency, and population statistics are reviewed. Screening 
and treatment recommendations are also reviewed, including the recommended daily 
allowance of vitamin D, sun exposure, and supplementation strategies.  
Data Sources: Clinical studies, literature review articles, consensus guidelines, and the 
Institute of Medicine (IOM) recommendations. 
Conclusions: Although there is disagreement regarding the definition of vitamin D 
deficiency, recent literature confirms the following information.  Risk factors include 
poor dietary intake, decreased sun exposure, darker skin pigmentation, genetics and 
obesity. Vitamin D deficiency is common. Vitamin D repletion involves increasing 
dietary intake, limited sun exposure, and vitamin D supplementation.  For most 
individuals vitamin D supplementation is a necessary component of repletion and 
maintenance.  High-dose vitamin D2  (50,000IU) and vitamin D3 can be used safely and 
effectively. 
Implications for Practice:  Given that treatment of vitamin D deficiency is known to 
promote bone health and is likely to enhance immune response and decrease morbidity, 
understanding of appropriate screening, diagnosis, and management of vitamin D 
deficiency is essential for the nurse practitioner. 
Key words: vitamin D deficiency; hypovitaminosis D; vitamin D supplementation  
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What is Vitamin D? 
When the minimum dose of vitamin D to prevent rickets was recognized, many 
healthcare providers did pay attention to vitamin D or the implications of vitamin D 
deficiency. In recent years, however, studies emerged demonstrating that large segments 
of the United States (US) population suffer from vitamin D deficiency or 
hypovitaminosis D (Holick, 2007). Vitamin D is a fat-soluble vitamin which is dependent 
on oral consumption from foods that are naturally rich in the vitamin or fortified, such as 
fish, eggs, and milk or vitamin D supplementation.  Additionally, vitamin D can be 
synthesized under ultra-violet (UV) exposure in the skin (Bohaty, Rocole, Wehling, & 
Waltman, 2008).  
Vitamin D from food, supplements, and sun exposure is biologically inert and 
must undergo two hydroxylations before it is biologically active. Vitamin D is first 
metabolized in the liver to 25-hydroxyvitamin D [25(OH) D3] also known as calcidiol. 
Next, calcidiol is metabolized in the kidneys into 1,25-dihydroxyvitamin D [1,25(OH)2D] 
also known as calcitriol. Calcitriol is the active from of vitamin D.  This conversion is 
tightly regulated by plasma parathyroid hormones and serum calcium and phosphate 
levels (Holick & Chen, 2008). Because, calcitriol, has an extremely short half-life, it does 
not offer an adequate reflection of vitamin D status; therefore, the intermediary form of 
vitamin D, 25(OH)D or calcidiol, is routinely checked via serum concentration to 
determine vitamin D status.  Vitamin D, 25(OH)D has a half-life of 15 days.  Serum 
measurement of 25(OH)D does not reflect the amount of vitamin D that is stored in body 
tissues, mainly adipose tissue (Hollis, Wagner, Drezner, & Binkley, 2007) 
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What is Vitamin D Deficiency? 
Controversy exists regarding the definition of vitamin D deficiency and 
insufficiency.  Two organizations, The Endocrine Society and the Institute of Medicine 
(IOM), differ in their definitions for vitamin D levels. The traditional definitions of 
normal, insufficient, and deficient vitamin D, as defined by the Endocrine Society, are as 
follows (the unit ng is currently used in current practice and lab reports): 
Vitamin D deficiency: Serum 25OHD less than 50nmol/mL (20ng/mL) 
Vitamin D insufficiency: Serum 25OHD between 50 – 72.5nmol/mL               
(20-29ng/mL) 
Vitamin D sufficiency: Serum 25OHD more than 75nmol/mL (30ng/mL)     
These figures were determined by examining the relationship between vitamin D and 
serum parathyroid hormone (PTH).  PTH is increased when vitamin D is low suggesting 
a positive feedback; however, when serum Vitamin D levels reach 30ng/mL to 40ng/mL  
parathyroid hormones level off.  Additionally, with an increase in serum vitamin D levels 
from 20ng/mL to 30ng/mL calcium absorption from the gut is increased from 45% to 
65% (Holick et al., 2011). 
In November of 2010 the IOM released a report on the status of vitamin D in the 
United States. The following are their definitions of normal and inadequate vitamin D 
levels as defined by the IOM (the unit ng is used in current practice and lab reports): 
At risk of vitamin D deficiency: Serum 25OHD less than 30nmol/L (12ng/mL)  
At risk of vitamin D inadequacy: Serum 25OHD 30–49nmol/L (12–19ng/mL)  
Sufficient in vitamin D: Serum 25OHD 50–125nmol/L (20–50ng/mL)  
(Institute of Medicine, 2010) 
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These numbers were determined by examining the relationship between vitamin D levels 
and bone health.  The IOM states that a serum vitamin D level of 20ng/mL is what is 
necessary for healthy bone development. The IOM did not consider vitamin D levels in 
association with other disease states other than bone health for the establishment of the 
current norms.  Because of the sole focus on bone health, these new standards were met 
with contention from providers in specialist communities such as endocrinology, 
rheumatology, and oncology (Heaney & Holick, 2011; Maxmen, 2011).  
What About Vitamin D and Other Diseases Besides Bone Health? 
Even though the IOM report did not find sufficient evidence to definitively 
associate vitamin D with disease states other than poor bone health, many studies are 
suggesting that these associations could become more clear in the future.  Vitamin D is 
known to be the primary regulator of over 600 crucial genes.  Additionally, the discovery 
that most cells in the body have a vitamin D receptor suggests that the vitamin could have 
many more functions within the body than previously thought (Holick, 2007). Vitamin D 
has been found to be crucial for a healthy immune system and deficient states are 
associated with higher rates of reactivated tuberculosis (Hewison, 2010). A study 
performed at the Mayo Clinic in Minnesota, found that 93% of patients whose chief 
complaint was nonspecific musculoskeletal pain were deficient in vitamin D (Plotnikoff 
& Quigley, 2003).  Vitamin D deficiency has been linked as a risk factor, as well as, a 
factor in treatment to several different forms of cancer including colon, prostate and 
breast cancer (Mitchell, 2011; Spina et al., 2006).  Furthermore, it has been suggested 
that vitamin D can also have an influence on common age-related morbidities including 
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falls, dysphagia, urinary incontinence, and cognitive decline (Binkley, 2007; Bischoff-
Ferrari, Giovannucci, Willett, Dietrich, & Dawson-Hughes, 2006). 
Evidence also suggests that vitamin D deficiency may play a role in the 
development of type 2 diabetes mellitus (DM2).  Vitamin D may have a direct role in 
insulin secretion and the utilization of insulin by peripheral tissue.  It is hypothesized that 
binding of circulating 1,25-dihydroxyvitamin D (the active form of vitamin D) to the 
pancreatic β-cell vitamin D receptor promotes insulin secretion (Peechakara & Pittas, 
2008).  Additionally, the regulation of calcium levels by vitamin D can also indirectly 
promote β-cell insulin secretion by maintaining a consistent flux of calcium into the cell.  
Finally, it also appears that vitamin D stimulates the expression of insulin receptors on 
target-tissues which facilitates the uptake and use of insulin (Penckofer, Kouba, Wallis, 
& Emanuele, 2008). 
What Are the Risk Factors for Vitamin D Deficiency? 
Risk for vitamin D deficiency is multifaceted and can include non-pathologic 
factors such as dietary intake, sun exposure, race, genetics, and obesity.  Pathologic risk 
factors for vitamin D deficiency (which are beyond the scope of this report) include liver 
failure, nephritic syndrome, chronic kidney disease, and diseases of the parathyroid 
gland.      
Nutrition 
As demonstrated in table 2, only a few foods supply a noteworthy amount of 
vitamin D. Of those foods, fish and cod liver by far contain the greatest amount of 
vitamin D.  A lack of fresh fish can be an issue in many parts of the country (especially 
the Midwest) where fish is not fresh and therefore is not part of daily or even weekly diet. 
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Unfortunately fatty fish that is high in vitamin D, can also contain high levels of mercury 
which would limit the intake for pregnant women.  Additionally, conditions such as 
lactose-intolerance limit the intake of milk and other dairy products.  Due to the fact that 
most foods have very little vitamin D and dairy products are poorly tolerated by some 
individuals, diet is generally regarded as a poor source for vitamin D (Holick, 2011).   
Finally, vitamin D is poorly transferred via breast milk.  When breast milk is the sole 
source of nutrition, infants are at high risk for vitamin D deficiency (Hollis & Wagner, 
2004).  
UV Light Exposure 
Considering the minimal impact of diet on vitamin D status, ultra-violet (UV) 
light exposure from the sun is a primary and sufficient source of vitamin D. Due to the 
consistent findings, however, of low vitamin D levels throughout the United States 
population the importance of sun exposure in maintaining adequate vitamin D levels is 
being called into question (Adams & Hewison, 2010).  Melanin is the pigment that is 
primarily responsible for skin color.  Highly pigmented skin does not absorb vitamin D as 
well as skin with less melanin. Vitamin D is synthesized in the skin by the action of UV-
B. High melanin content in the skin reduces UV-B exposure and consequently cuts the 
conversion of 7-dehydrocholesterol (7-DHC) to pre-vitamin D which is the first step in a 
chain of reactions that ends in active vitamin D (Hollis et al., 2007).  As global 
immigration becomes more prevalent, individuals with high skin melanin content are 
living at higher latitudes.  The decrease in sun intensity found at higher latitudes and in 
more seasonal climates, impacts the ability to synthesize an adequate amount of vitamin 
D from sunlight and results in higher rates of vitamin D deficiency in individuals with 
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darker skin pigmentation. It has been demonstrated that even with significant, long-term 
sun exposure populations with darker skin have decreased levels of vitamin D (Binkley et 
al., 2007; Nesby-O'Dell et al., 2002; Sahu et al., 2009). 
Use of Sunscreen 
Topical sunscreen agents interfere with the exposure of skin to UV-B radiation, 
thereby decreasing the amount of UV-B converted to pre-vitamin D.  The higher the sun 
protection factor (SPF) the more that the sunscreen, by definition, will decrease UV-B 
exposure (Tsiaras & Weinstock, 2011).  There are very few studies that have measured 
the effect of sunscreen use on vitamin D levels.   
Study results on the use of sunscreen and vitamin D differ.  One study, completed 
in 1988, found that serum vitamin D levels were 64% lower in 20 individuals who were 
habitual sunscreen users than their 20 sun-exposure matched control subjects  (Matsuoka, 
Wortsman, Hanifan, & Holick). However, a randomized controlled trial in Australia, 
noted little difference between placebo and control groups in relation to the effect of 
sunscreen use on serum vitamin D levels (Marks et al., 1995). With this mixed 
information it is difficult to determine the role sunscreen use plays in vitamin D 
deficiency.  It has been suggested that typical sunscreen use may play only a minimal role 
considering that most individuals apply less than the suggested, effective amount of 
sunscreen initially and only 43% of individuals reapply at regular intervals (American 
Academy of Dermatology, 2008).   
Genetics 
Genetics is also an emerging factor in the development of vitamin D deficiency.  
After examining genetic profiles of various groups of Hispanic and African Americans 
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and analyzing serum vitamin D levels, Engelman et al. found that polymorphisms in the 
vitamin D binding protein (VDP) gene do exist and in some cases were associated with 
lower levels of serum vitamin D (2008).  As with many other disease states, genetics is an 
emerging field and further studies are needed to confirm if certain genetic mutations can 
lead to vitamin D deficiency. 
Obesity 
Obesity is another risk factor in the development of vitamin D deficiency. 
Vitamin D is readily absorbed by adipose tissue and is saved for subsequent release and 
metabolism when there is a need during the winter months.  However, when there is a 
larger pool of adipose tissue, the sequestration of vitamin D is associated with poor 
bioavailability (Holick, 2007). Therefore, levels of vitamin D in obese individuals tend to 
be 57% lower than their age-matched, normal weight controls (Wortsman, Matsuoka, 
Chen, Lu, & Holick, 2000). 
What is the Epidemiology of Vitamin D Deficiency? 
Many studies have determined that large segments of the United States population 
are either insufficient or deficient in vitamin D.  A large cross-sectional cohort study that 
analyzed data from the National Health and Nutrition Examination Survey (NHANES 
III) determined that mean levels of 25(OH) D3 were lower in Latinos and African 
Americans than their white counterparts. Additionally, women had lower levels of 
vitamin D across all age ranges and races (Zadshir, Tareen, Pan, Norris, & Martins, 
2005).  This study determined that 34% of white men and 45% of white women had 
insufficient levels of vitamin D. Insufficiency rates were even higher in minority 
populations.  Seventy-six percent of Latino men and 77% of Latino women were 
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insufficient while 55% of black men and 72% of black women had inadequate levels of 
vitamin D. Even though sun-exposure can impact and sometimes improve vitamin D 
levels, several studies demonstrate that even in sun-rich areas inadequate levels of 
vitamin D is still pervasive in the population.  Jacobs et al. states that even in sun-rich 
Arizona 25% of the population is deficient in vitamin D (<20ng/mL).  When identifying 
subjects who are insufficient and deficient (<30ng/mL), the percentage increases to 76%.  
Again, minorities have higher rates of insufficiency and deficiency than their white 
counterparts.  While 75% of whites were either insufficient or deficient, 87% of Latinos 
and 88% of Blacks were lacking adequate vitamin D (2008).  A study that examined 
subjects in sun-rich Florida determined that 39% of their overall study population was 
deficient in vitamin D compared with 25% in the Arizona study (Levis et al., 2005).  In a 
study performed in sun-rich Honolulu, Hawaii, it was found that 51% of the 93 university 
students tested had low vitamin D status (Binkley et al., 2007).  
What is the Current Dietary Allowance of Vitamin D? 
Even though there is overwhelming evidence that indicates that large segments of 
the United States populations, and especially the darker-skinned minority populations, 
have low levels of vitamin D, the IOM  stated in their report that most North Americans 
have sufficient intake of vitamin D to support bone health (Institute of Medicine, 2010).  
As stated previously the IOM determined that currently there is not enough scientific 
evidence to definitively link vitamin D to other diseases such as cancer, diabetes, 
rheumatologic conditions or increased risk for infection; therefore, adequate levels of 
vitamin D for the prevention of other pathologies were not considered in the 
recommendations.  Even though the committee stated that most individuals have 
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sufficient intake of vitamin D, by current standards, they recommended that the Food and 
Nutrition Board increase the recommended daily allowance (RDA) of vitamin D for 
adults ages 18-70 years old from 400IU to 600IU per day.  These types of inconsistencies 
have fueled further criticism of the IOM report. Medical providers have challenged the 
homogeneity of the committee members, the institute’s consistent recommendations for 
the entire North American population regardless of race or residential latitudes, and many 
disagree with the IOM’s sentiment that with few exceptions, all North Americans are 
receiving enough vitamin D (Maxmen, 2011; Plotnikoff, 2011).   
Who Should be Screened for Vitamin D Deficiency? 
The IOM report did not provide any recommendations regarding the screening of 
vitamin D.  By increasing the recommended daily intake level, the committee suggested 
that all individuals that consume 600IU of vitamin D per day will maintain blood levels 
greater than the 20ng/mL needed for bone health (Institute of Medicine, 2001).  The 
Endocrine Society, however, does suggest in their guidelines that individuals at high risk 
for deficiency should be screened (Holick et al., 2011). Because of its longer half-life, the 
intermediary form of vitamin D, calcidiol, or 25(OH)D, should be the only lab test used 
for the screening of serum vitamin D (Hollis et al., 2007).  
What is the Best Way to Treat Vitamin D Deficiency? 
The IOM report provided little structure for vitamin D repletion in the case of 
vitamin D deficiency.  Patient education regarding appropriate food intake is an 
important factor in the treatment for vitamin D deficiency.  However, most foods provide 
only a small amount of the recommended dietary intake of vitamin D.  Additionally, 
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barriers such as lack of personal taste for fish, cost of fish, mercury content, and dietary 
intolerances make dietary changes challenging.   
Because there are a limited number of foods that contain significant amounts of 
vitamin D and  prolonged sun exposure is associated with an increased risk of skin 
cancer, vitamin D supplementation is a safe and effective method of achieving adequate 
serum levels (American Academy of Dermatology, 2008).  According to the Endocrine 
Society guidelines, most high-risk individuals will need vitamin D supplementation to 
achieve and maintain sufficient serum levels of vitamin D (Holick et al., 2011). The IOM 
report suggests that the goal for treatment be lowered to 20ng/mL, whereas, the 
Endocrine Society report recommends that patients maintain a level of 30ng/mL to 
50ng/L.  Finally, the IOM report recommends 60ng/mL as the upper threshold of safe 
serum vitamin D levels (Institute of Medicine, 2010).  At levels above 60ng/mL it is 
unknown what potential negative or adverse effects may occur.  
There are two different forms of vitamin D supplementation currently available 
on the market, vitamin D2 or ergocalciferol and vitamin D3 or cholecalciferol. Vitamin D2 
is obtained from plant material and enters the circulation via the same pathway as 
supplemented foods.  Vitamin D3, while also taken orally, is more similar to 7-
dehydrocholesterol that is formed when UV light enters the skin (Stechschulte, Kirsner, 
& Federman, 2009). Vitamin D3 is also found in natural fish sources such as cod liver oil, 
salmon, mackerel, and herring. Studies demonstrate that both vitamin D2 and vitamin D3 
have similar capacity to increase serum vitamin D levels  (Cannell, Hollis, Zasloff, & 
Heaney, 2008).  Vitamin D2 is available by prescription only.  It is a high dose capsule, 
50,000IU, which allows for weekly dosing and is only useful in the treatment of deficient 
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states.  Conversely, vitamin D3 which is available over-the-counter, provides variable 
dosing from 200IU to 4000IU. This type of dosing is traditionally more useful in daily 
maintenance or treatment of mild insufficiency.   
Most traditional regimens for vitamin D repletion include several weeks of high-
dose therapy (either once weekly or three times a week for 4 to 12 weeks) and then 
maintenance on lower dose therapy. In 2008, Pepper et al. evaluated a variety of repletion 
regimens that included only vitamin D2. The study concluded that regimes which 
contained at least 600,000IU of vitamin D2 appeared to be the most effective in treating 
vitamin D deficiency and that the actual regimen of how this was achieved was 
inconsequential.  In 2011, Papaioannou et al. challenged the traditional regimen in a 
study of 65 elderly, hip-fracture patients with low vitamin D.  The subjects were 
randomized into 3 treatment groups.  The groups differed only by the bolus amount of 
vitamin D given at the start of therapy.  One group was placebo and did not receive a 
bolus while the second and third groups received a one-time bolus of 50,000IU and 
100,000IU of vitamin D2 respectively.  After the one-time bolus dose all three groups 
were given 2,000IU of vitamin D3 to take daily for 90 days. Surprisingly, the results of 
the serum 25(OH)D levels, demonstrated no difference among the three groups.  This 
suggests that high (bolus) doses of vitamin D2 may not always be necessary for vitamin D 
repletion.   
There is not one method to treating vitamin D deficiency.  Further studies are 
needed to determine if weekly high-dose therapy or daily low-dose therapy is best for 
repletion.  It appears that vitamin D repletion by any method should be successful; 
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therefore, the nurse practitioner should consider patient compliance and patient 
preferences regarding high-dose versus low-dose regimens.   
Conclusion 
There are still many inconsistencies and controversies surrounding vitamin D 
deficiency which can be very confusing for the nurse practitioner.  Achieving goals of 
serum 25(OH)D levels of greater than or equal to 30ng/mL will not cause harm to the 
patient and may have increased benefit over a maintenance level of greater than 
20ng/mL.  Patients who are at high-risk for vitamin D deficiency should be screened.  
There is no consensus on “best-practice” repletion strategies; however, use of vitamin D2 
and/or vitamin D3 seem to be equally effective in mitigating deficiency and do not appear 
to cause harm as long as serum 25(OH)D levels stay below 60ng/mL. Nurse practitioners 
should be aware of the risk factors for vitamin D deficiency, screen high risk patients, 
and initiate a treatment and maintenance regimen to sustain a sufficient state.    
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Table 2 
Sources of vitamin D 
Food     IUs per serving 
Cod liver oil (1 tbsp).  1,360 
Salmon (3oz)     447 
Mackerel (3.5oz, cooked)   345 
Sardines (1.75 oz, canned) 250 
Tuna fish (3 oz, canned)   200 
Milk (1cup, fortified)    117 
Orange juice (1 cup, fortified)  100 
Cereal (1 cup, fortified)   100 
Margarine (1 tbsp, fortified)  68 
Egg (1whole)       41 
Swiss cheese (1 oz)      18 
 
IU = International Unit 
(Institute of Medicine, 2010) 
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Abstract 
Purpose: To explore Nurse Practitioner (NP) knowledge of vitamin D and vitamin D 
deficient states and appropriate testing, risk factors, and treatment of low levels of 
vitamin D.   
Data Sources:  A descriptive, exploratory survey of 100 NPs at a national conference.  A 
17 item questionnaire included four main sections: demographic information, knowledge 
items, and treatment of vitamin D as well as a question on frequently used sources for 
information on vitamin D. 
Conclusions: NP knowledge of vitamin D is inconsistent to poor. NPs were able to 
consistently identify a limited number of risk factors for low vitamin D. Identification of 
the appropriate lab testing occurred 59% of the time and NPs identified laboratory result 
thresholds for diagnosis only 51% of the time.  Almost 40% of NPs did not know that 
vitamin D could reach toxic levels in the body. Only 2% of NPs were able to accurately 
identify the current recommended daily allowance of vitamin D for adults and only 16% 
identified the correct RDA for the elderly. NPs were unaware that several chronic 
diseases have been associated with low vitamin D. Even though vitamin D 
supplementation was commonly used for treatment, the recommended dosage and 
frequency of treatment varied greatly.  
Implications for Practice: It is crucial that NPs have the knowledge they need to assess 
and treat vitamin D deficiency. Maintaining adequate vitamin D levels is a cost-effective 
way to prevent or adjunctively treat many chronic diseases. NPs need additional 
education on the diagnosis and treatment of vitamin D deficiency.  
Key words: vitamin D deficiency; hypovitaminosis D; vitamin D supplementation 
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Vitamin D Knowledge among Nurse Practitioners 
Background 
 Vitamin D is a fat soluble vitamin that is most recognized for its role in bone 
health where deficiency results in rickets/osteomalacia due to poor calcium absorption in 
the gut (Binkley, 2012).  Decreased vitamin D levels are sub-divided into 2 categories, 
insufficiency and deficiency, and are defined by the Endocrine Society as follows the unit 
ng is used in current practice and lab reports: 
Vitamin D deficiency: Serum 25OHD less than 50nmol/mL (20ng/mL) 
Vitamin D insufficiency: Serum 25OHD between 50 – 72.5$nmol/mL (20-29 
ng/mL) 
Vitamin D sufficiency: Serum 25OHD more than 75nmol/mL (30ng/mL)  (Holick 
et al., 2011).   
Risk factors for vitamin D deficient states include: poor intake of dietary vitamin D, lack 
of ultraviolet (UV) light exposure, darker skin color, use of sunscreen, genetics, and 
obesity (Engelman et al., 2008; Holick, 2007).  
Vitamin D is known to be the primary regulator of over 600 crucial genes.  In 
addition most cells in the body have a vitamin D receptor suggesting that the vitamin 
could have many more functions in the body than previously thought (Holick, 2012). 
Recent evidence suggests that vitamin D deficiency could play a role in the development 
of all types of diabetes due to its roles in insulin secretion and the utilization of insulin by 
peripheral tissue (Takiishi, Gysemans, Bouillon, & Mathieu, 2012). Vitamin D deficiency 
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is also linked to several forms of cancer including colon, prostate and breast cancer 
(Mitchell, 2011; Spina et al., 2006). Vitamin D deficiency has also been associated with 
increased cardiovascular risk; decreased immune response to infection; increased risk of 
autoimmune disease and cognitive decline (Balion et al., 2012; Hewison, 2012; 
Muscogiuri et al., 2012). 
It has been demonstrated that large sections of the US population maintain low 
levels of vitamin D. A large cross-sectional cohort study that analyzed data from the 
National Health and Nutrition Examination Survey (NHANES III) determined that mean 
levels of 25(OH) D3 were lower in Latinos and African Americans than their white 
counterparts. Additionally, women had lower levels of vitamin D across all age ranges 
and races (Zadshir, Tareen, Pan, Norris, & Martins, 2005).  This study determined that 
34% of white men and 45% of white women had insufficient levels of vitamin D. 
Insufficiency rates were even higher in minority populations.  Vitamin D levels were 
insufficient in 76.2% of Latino men and 77% of Latino women while 55% of black men 
and 72% of black women also had inadequate levels of vitamin D. Even though sun-
exposure can impact and sometimes improve vitamin D levels, several studies 
demonstrate that even in sun-rich areas inadequate levels of vitamin D are still pervasive 
in the population.  Jacobs et al. (2008) states that even in sun-rich Arizona 25% of the 
population is deficient in vitamin D (<20ng/mL).  When identifying subjects who are 
insufficient and deficient (<30ng/mL) the percentage increases to 76%.  Again, minorities 
have higher rates of insufficiency and deficiency than their white counterparts.  While 
75% of whites were either insufficient or deficient, 87% of Latinos and 88% of Blacks 
were lacking adequate vitamin D (2008).  Another study that examined subjects in sunny 
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Florida determined that 39% of their overall study population was deficient in vitamin D 
compared with 25% in the Arizona study (Levis et al., 2005).  In a study performed in 
sun-rich Honolulu, Hawaii, it was found that 51% of the 93 university students tested had 
low vitamin D status (Binkley et al., 2007).  
According to the American Association of Nurse Practitioners, 89% of the 
140,000 nationally licensed Nurse Practitioners (NPs) are prepared in a primary care 
focus (adult, family, gerontology, pediatric or women’s health) (2013).  With current 
reports stating that such large portions of the population have low levels of vitamin D, it 
is likely that the nurse practitioner provider will need to recognize and treat patients with 
low vitamin D. It is important to ascertain the current level of knowledge of NPs 
regarding recognition, diagnosis and treatment of vitamin D deficient states.  This 
includes knowledge of risk factors for vitamin D deficiency, appropriate lab testing and 
interpretation, as well as treatment options.   It is crucial that NPs have the knowledge 
they need to effectively manage low vitamin D in order to mediate risk of poor bone 
health, musculoskeletal pain, and many chronic disease states.    
Purpose 
The purpose of this study was to explore NP knowledge of vitamin D and vitamin D 
deficient states as well as appropriate testing, risk factors and treatment of low levels of 
vitamin D. 
Methods 
Design, Study Sample and Data Collection Procedures 
 In this descriptive, exploratory study, a cross-sectional survey approach was used.  
After obtaining permission from the American Association of Nurse Practitioners 
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(AANP), surveys were made available to nurse practitioner attending the AANP 2012 
national conference in Orlando, Florida.  Questionnaires were placed on a table in the 
hallway of the convention center.  The investigator stood beside the table and asked nurse 
practitioners if they would be willing to respond to the survey.  Questionnaires were 
returned to a sealed collection box near the table.  One-hundred and fifty six surveys were 
distributed and collection was stopped when the number of completed and returned forms 
reached 100.  Participation was limited to actively practicing nurse practitioners.  
Students and nurse practitioners who were not actively practicing were excluded from the 
study.   
Instrument 
The investigator designed survey was developed using: a) an extensive review of the 
literature and   b) current guidelines  issued by the Endocrine Society regarding vitamin 
D (Holick et al., 2011). The 17 item questionnaire includes four main sections: 
demographic information, knowledge items, two questions on treatment and a single 
question on identifying resources used by nurse practitioners to learn about vitamin D 
deficient states.  The demographic section includes four questions. The knowledge items 
consist of both multiple choice items and one question that required participants to rank 
answers in order.  Initially the knowledge survey was a total of ten questions and 
included four questions on laboratory testing and interpretation of laboratory results, two 
questions on risk factors for vitamin D deficiency, one question on vitamin D content in 
foods and sunlight, two questions on recommended daily intake levels of vitamin D by 
the Food and Drug Administration (FDA), and one question on vitamin D and associated 
chronic conditions. However after statistical analysis the knowledge survey was reduced 
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to six questions.  The two questions pertaining to risk factors, the question on sources of 
vitamin D and association of vitamin D with chronic conditions were eliminated from the 
final knowledge assessment. Each question contained multiple parts and all parts needed 
to be correct for the entire question to be considered correct. The four questions were 
eliminated because the number of correct answers to those questions was so low that 
those questions were not useful in delineating NP knowledge.  Before the elimination of 
the questions the highest NP knowledge score was 6 points out of 10 which was also the 
case after the elimination of the questions. Additionally, the nature of the questions 
(needing to get multiple parts within the question correct to achieve an overall correct 
response) proved to be too challenging for most participants.  Even though the four 
questions were not used in the total knowledge score, participant responses were 
analyzed and results reported below.  
Human Subjects and Research Approval Procedures 
Prior to data collection all research team members met institutional researcher training 
requirements and the study protocol gained approval as exempt research by the 
University of Kentucky Institutional Review Board (IRB).  As approved by the IRB 
survey participants were informed in a preamble statement that their participation implied 
consent and that no identifying information would accompany their survey submission. 
Data Analysis 
 The Statistical Software for the Social Sciences (SPSS) version 20.0 was used to 
analyze data.  Both inferential and descriptive statistics were used to analyze data. 
Descriptive statistics included frequencies, means, standard deviations, and ranges. 
Comparisons and associations were calculated using independent t- tests and Pearson 
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product moment correlations. Results were reported as significant when a threshold of p 
< 0.05 was met.  
Results 
 Of the 100 participants in this sample 70% were nurse practitioners certified in 
family practice. Four other specialties were also represented.  Length of practice as a NP 
was reported M = 9.77 years (SD = 8.26) with a range of <1 to 40 years (see Table 3).  
Eighty percent of the participants reported evaluating and treating vitamin D deficiency 
in their practice.   
 Participant knowledge on vitamin D was based on answers to 6 multiple choice 
questions.  Scores ranged from zero to six with six representing the greatest knowledge 
(see table 4).  The mean knowledge score of nurse practitioner respondents was 2.30 (SD 
= 1.31).   The t-test for independent samples indicated a significant difference in the 
mean knowledge score between nurse practitioners who reported assessing and treating  
vitamin D deficiency in practice (t=2.903, p<.05, M=2.49, SD=1.27) compared to those 
who do not regularly assess vitamin D (M=1.55, SD=1.23).  No difference was found in 
the mean knowledge score when comparing Adult NP/Family NP versus other 
represented specialties (p=.670).  An examination of NP years of practice revealed a 
small correlation that was not significant (r=.086, p=.413).   
 Each knowledge score component was analyzed by frequency of correct versus 
incorrect answer (see Table 5).  Only 59% of respondents were able to identify the 
correct laboratory test used to determine serum vitamin D levels. Only 51% and 41% of 
respondents were able to identify the correct serum laboratory threshold for vitamin D 
insufficiency and deficiency, respectively.  When asked about vitamin D and toxicity, 
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only 61% responded correctly that vitamin D can reach levels of toxicity which could 
potentially be fatal.  Finally, only 2% of respondents knew the current recommended 
daily allowance (RDA) of vitamin D for adults and on 16% could identify the current 
RDA for elderly individuals greater than 70 years old.  
 Four questions that were separated from the knowledge score asked participants 
about risk factors for vitamin D deficiency, sources of vitamin D, and chronic diseases 
associated with vitamin D deficiency (see Table 6). When participants were given a list 
of seven potential patients and asked to identify the risk of that patient having vitamin D 
deficiency, their mean score was 3.64 (SD 1.33, ranger 0-7).  Respondents were most 
likely to misidentify two types of patients: a) Latino males who work outdoors and b) 3 
month old Caucasian infants who are exclusively breastfed both of whom are high risk. 
The patients who were more likely to be identified correctly were Latina woman who 
work indoors and Caucasian women who work a desk job both of whom are also high 
risk.  Only 2 of the respondents were able to identify the correct risk status for all 7 
potential patients. 
 When participants were given a list of patient characteristics and asked to identify 
which of the characteristics indicate high risk or low risk for vitamin D deficiency, 
respondent’s mean score was 4.71 (SD 1.0, range 0-7).  The most common characteristics 
that participants misidentified were: having brown or olive skin tone (high risk), having 
white skin tone with freckles (low risk), and having dark black skin (high risk). Most of 
the respondents were able to correctly identify that little sun exposure and obesity were 
both high risk characteristics for vitamin D deficiency. None of the respondents were able 
to correctly identify all seven risk variables.  
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 When given a list of sources of vitamin D and asked to rank them in order from 
best to least participants overall did very poorly.  Most participants only ranked one or 
two items in the correct order (M=1.56, SD 1.54, range 0-7)   
 Participants were also asked about specific chronic diseases and their association 
with vitamin D.  All of the diseases on the list have been associated with low vitamin D 
status.  It is important to note that little research has investigated causality between low 
vitamin D and these chronic diseases; however, in all cases patients with these chronic 
diseases are found to have an increased incidence of vitamin D deficiency.  Greater than 
87% of respondents clearly identified that osteoporosis, osteomalacia, and muscle or 
bone pain are chronic conditions that are highly associated with vitamin D deficient 
states. Conversely, respondents were less likely (20 to 50%) to associate vitamin D 
deficiency with individuals who have asthma, type 2 diabetes, and increased number or 
severity of infections.  Other chronic diseases such as cancer, depression and autoimmune 
disease were identified as associated with vitamin D deficient states 56 to 68% of the 
time.  
 Nurse practitioners were then asked about their treatment preferences for vitamin 
D deficiency (see Table 7). Sixty-six percent of respondents stated that they would 
recommend an increase in intake of vitamin D rich foods as a part of their treatment plan.  
Respondents also recommended vitamin D supplementation a majority of the time; 
however, the dosage of supplement and frequency varied greatly with the very high dose 
50,000 IU weekly dose recommended by 66% of NP respondents. Lastly, 75% of nurse 
practitioners stated that they would increase sun exposure as part of the treatment plan; 
however, sun exposure carries its own inherent risks.   
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 Finally, participants were asked to identify which sources they were likely to use 
for new information on vitamin D.  The data suggests that NPs obtain their information 
from a variety of sources including colleague discussion, physician and NP targeted 
journal articles, medical internet sites (non-journals) such as Web MD or the Mayo clinic, 
and medical conference presentations.  NPs also responded that they sometimes or often 
use Wikipedia (51%) and non-medical magazines such as Ladies Home Journal or Good 
Housekeeping (27%) for medical information (see Table 8).      
Discussion 
 Accurate knowledge regarding vitamin D deficiency is critical if NPs are going to 
make optimal patient care decisions related to vitamin D deficient states.  Finding of this 
study show that NP knowledge of vitamin D and its deficient states is inconsistent.  Even 
though NPs were able to identify some risk factors for vitamin D deficiency such as 
decreased sun exposure and obesity, other important risk factors such as darker skin color 
and breastfed infants were missed.  NPs that are unaware of all of the major risk factors 
for vitamin D deficiency may not screen patient’s appropriately not only leading to an 
unrecognized problem but also lack of treatment.   
 Even when patient risk is screened appropriately, many critical elements of 
vitamin D testing and treatment can be confusing.  NPs need to be able to identify the 
appropriate lab test used for serum vitamin D assessment and the critical lab levels that 
indicate vitamin D deficiency states.   When it comes to treatment NP knowledge is again 
inconsistent.  Sixty-six percent of NP participants stated that they would increase food 
intake of vitamin D as part of their treatment plan; however, very few NPs were able to 
correctly identify the current RDA for vitamin D in either the adult or elderly population.  
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Most NPs were unable to correctly rank foods containing the most to least vitamin D 
which indicates that NPs may not know what foods are high in vitamin D.  Additionally, 
even though it is important to incorporate vitamin D rich sources into a treatment plan, 
NPs also need to consider that only a few foods supply a noteworthy amount of vitamin 
D and that some of the best sources are fish.  The importance of fish can be an issue in 
many parts of the country where fish is not fresh; therefore, not a part of the daily or even 
weekly diet.  Incorporating fish in a diet is a special challenge for pregnant women 
because the same fatty fish that is high in vitamin D can also be high in mercury, limiting 
weekly intake.  NPs need to have a better awareness of current recommendations and 
which sources of vitamin D are best in order to appropriately guide patients.  
  Additionally, even though most NPs state that they would provide some level of 
vitamin D supplementation as a part of their treatment plan, surprisingly 40% of 
respondents were unaware of the risk of vitamin D toxicity and death.  Vitamin D is a fat 
soluble vitamin and although rare, cases of toxicity are reported annually usually in cases 
where serum vitamin D levels are greater than 200ng/mL (Lowe, Cusano, Binkley, 
Blaner, & Bilezikian, 2011; Maji, 2012).  Furthermore, there was a wide range of 
supplementation strategies used by NPs in current practice with doses ranging from 400 
to 2000IU daily to 50,000 IU per week.  This suggests that there is marked variation in 
current vitamin D repletion strategies.  Finally, 75% of nurse practitioners would 
recommend an increase in sun exposure as part of their treatment plan; however, use of 
sunscreen blocks the UVB rays that are essential to vitamin D production. Sun exposure 
without the use of sunblock would expose patients to the harmful effects of the UV rays.  
The American Academy of Dermatology recommends against the use of UV light 
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exposure as a treatment for vitamin D deficiency stating that the risks associated with 
exposure do not outweigh benefits especially when other forms of supplementation are 
available (2008). 
 In addition to inconsistent NP knowledge regarding vitamin D assessment and 
treatment, there is also a lack of awareness of the potential consequences and/or co-
morbid conditions that are associated with low levels of vitamin D. Even though many 
NPs associate bone diseases such as bone pain, osteoporosis and osteomalacia with 
vitamin D deficiency, NPs were less aware that cancer, increased risk for severe 
infections, asthma, depression and autoimmune disease all have been associated with 
vitamin D deficiency.  It is important that NPs are aware of the association between 
vitamin D deficiency and chronic disease.  This knowledge can be used to screen 
additional patients who may not have traditional vitamin D risk factors and appropriate 
vitamin D repletion in those patients could augment traditional treatment strategies for 
their condition. 
   Finally, NPs are asked to make critical decisions regarding patient care and it is 
important that the NP obtains accurate information from credible sources.  It is not 
surprising that most NPs turn to peer-reviewed medical journals for medical updates and 
information on vitamin D.  Conference speakers and reliable colleagues can also be a 
resource for NPs.  However NPs should be aware that medical websites, sites such as 
Wikipedia, and non-medical magazines are not optimal sources of information.  
Information in any of these sources may not be evidence based and can potentially 
increase confusion about medical topics.  NPs should be reminded that evidence based 
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practice is the gold standard for treatment and that medical journals are the best source 
for peer- reviewed articles and information. 
Limitations 
 Findings of the study are limited to a convenience sample of only 100 
respondents.  The sample was relatively homogenous with 80% of the respondents 
reporting their specialty as family nurse practitioner.  The choice for respondent 
anonymity eliminated the ability for future follow up.  Notwithstanding these limitations 
this study brings insight into the knowledge base of NPs regarding vitamin D deficient 
states and holds implications for education and practice.  
Implications for Practice 
 Nurse practitioners should consider assessment for vitamin D deficiency in any 
patient with traditional risk factors or commonly associated co-morbid conditions.  If 
nurse practitioners decide to treat vitamin D deficient states, they need to accumulate a 
knowledge base regarding risk factors, appropriate lab testing and evaluation, and 
treatment standards.  Treatment plans should be based on thorough knowledge of the 
sources of vitamin D, vitamin D supplementation strategies and risks of treatment. NPs 
should carefully consider the risks of having patients increase sun exposure (without 
sunscreen) before recommending sun exposure as a treatment for low vitamin D. Diet 
alone is generally regarded as a poor source of vitamin D especially in individuals who 
will not eat fish and/or dairy products and even though increasing dietary intake can be a 
valid part of a treatment plan, changing diet alone may not be sufficient.  NPs should also 
be aware of the recommendations created by the Endocrine Society for testing and 
treatment and use those recommendations as a guide to practice.   
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Table 3     Demographics of the study sample (N=100)  
 
Characteristic     N  % 
NP Specialty Certification 
   Family     70  70 
   Adult     17  17 
   Pediatric      1   1 
   Acute Care      4   4 
   Psychiatric     1   1 
   Dual Certification    5   5 
Currently treating vitamin D deficiency   
  Yes      80  80 
  No      20  20 
Years Practicing 
  <1year      7   7 
  2-5 years     23  23 
  6-10 years     28  28 
  11-15 years     13  13 
  16-20 years      9   9 
  21 – 25 years      2   2 
  >25 years      5   5 
 
 
 
Table 4  Knowledge scores (range 0-6)  _   
 
Total Score  N  % 
0    8  8 
1   24  24 
2   22  22 
3   25  25 
4   18  18 
5   3  3 
6   0  0   
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Table 5  Knowledge score 
components_____________________________________________________ 
 
Component         N 
Which laboratory test is used to determine Vitamin D levels?    
   Correct         59   
   Incorrect         41   
What is the serum lab value for vitamin D insufficiency? 
  Correct         51   
  Incorrect         49   
What is the serum lab value for vitamin D deficiency?     
  Correct         41   
  Incorrect         59   
Can vitamin D toxicity occur?  
  Correct         61   
  Incorrect         39   
What is the RDA of vitamin D for Adults ages 19 – 69yo? 
  Correct         2    
  Incorrect         98   
What is the RDA of vitamin D for elderly adults >70yo? 
  Correct         16   
  Incorrect         84   
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Table 6  Knowledge score components eliminated from final Instrument 
 
Question 1: A list of potential patients was given and participants were asked to mark (√) 
their perception of each patient’s risk for having less than normal vitamin D levels. They 
could choose high risk, low risk or I don’t know.  Descriptions of the patients included: 
                %correct 
(N=100) 
55 year old Latino Male who works outside riding horses    6% 
     A Caucasian 3 month old who is exclusively breastfed      33% 
     An obese 39 year old African American female      86% 
     A Caucasian 9 year old girl with a normal BMI     78% 
     A 32 year old Caucasian female with a normal BMI that runs marathons 80% 
     A 22 year old Latina female who is underweight and works at a grocery store 91% 
     A 45 year old Caucasian female who is overweight and works a desk job 97% 
 
Question 2:  A list of specific risk factors and participants were asked to mark (√) their 
perception of each characteristic and its risk relationship for less than normal vitamin D 
levels. 
                 % correct 
(N=100)     
    Being underweight         17% 
    Relatively little time in the sun       95% 
    Beige skin with brown or olive tone- Mediterranean/Latino   38% 
    Obesity          74% 
    White –very fair skin with freckles      19% 
    Dietary intake high in fatty fish       73% 
    Dark Black skin         48% 
 
Question 3:  Participants were asked to rank in order from 1 to 7 the best sources of 
vitamin D (best=1) to the worst (worst=7) sources of vitamin D. The sources are listed 
below. 
a. Fortified milk (1 cup)   
b. Tuna, canned (3.6oz) 
c. Egg yolk (1 egg) 
d. Raw broccoli (1 cup) 
e. Wild salmon(3.6 oz) 
f. Exposure to sunlight (15 minutes) 
g. Whole grain cereal (1 cup) 
 
Question 4: Participants were given a list of chronic conditions and asked if those 
conditions are associated with vitamin D. The answer choices were yes, no, or maybe. 
         Yes no maybe 
(N=100)    
    Type 2 diabetes      50 13 37 
    Osteomalcia/falls      94 2 4 
    Increased risk of falls      72 11 17 
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    Muscle/bone pain      87 1 12 
    Cancer       56 10 34 
    Asthma       19 43 38 
    Osteoporosis      94 0 6 
    Increased severity frequency of infections   50 11 39 
    Depression       68 8 24 
   Autoimmune disease     64 7 29 
 
 
Table 7 Treatment preference for vitamin D deficiency 
 
Treatment      Consider  Not consider 
(N=100) 
Increase intake of vitamin D rich foods      66   
 31 
Increase sun exposure         75   
 25 
400-1000IU daily vitamin D supplementation     10   
 90 
2000IU daily vitamin D supplementation      40   
 60 
50,000IU weekly vitamin D supplementation     66   
 34 
 
 
 
 
Table 8 Likely use of resources for information on vitamin D (N=100) 
 
Source        Never        Sometimes       Very 
Often 
Colleague discussion       20%  52%  28%  
Conference Speaker       35%  47%  18% 
Internet website other than journal (Web MD, Mayo) 15%  49%  36% 
Medical (Physician targeted) journal articles    20%  45%  35% 
Medical (NP targeted ) journal articles    16%  41%  43% 
Internet – Wikipedia       49%  35%  16% 
Non medical magazine       73%  24%  3% 
 
 
 
 
 
 
 
 
70 
 
 
 
 
Conclusion to Final DNP Capstone Report 
 
Sara E Robertson 
 
University of Kentucky 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
Vitamin D deficiency is pervasive in the United States population and has now 
been associated with many acute and chronic conditions, especially bone disease and type 
2 diabetes. Nurse practitioners are expected to make critical decisions regarding patient 
care and it is important that they have a good understanding of vitamin D deficiency 
ensuring that they can appropriately treat patients.  The research in this capstone indicates 
that NPs have a significant knowledge deficit regarding the assessment and treatment of 
vitamin D deficiency.  Optimal knowledge should include the definition of vitamin D 
insufficiency and deficiency and its correlation to chronic disease states, the risk factors 
and epidemiology of vitamin D deficiency, and the latest information on appropriate 
clinical screening and treatment of vitamin D deficiency as detailed in the second 
manuscript.   
Even though vitamin D deficiency research is in a nascent stage, early research 
indicates that recognition and treatment could benefit patients.  Through examining the 
current state of knowledge regarding vitamin D deficiency one can identify areas for 
education as well as future research potential. The potential of Vitamin D 
supplementation, which is easily accessible and inexpensive, to benefit public health is 
immense and worth the attention of both researchers and clinicians now and in the future. 
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Appendix A 
The Nurse Practitioner and Vitamin D: Knowledge and Practices 
Please indicate your answer to the following questions.  
Demographic Information 
1.Are you currently practicing in a nurse practitioner role? 
_____  yes ______ no 
2.Which of the following best describes your nurse practitioner specialty certification? (If 
you are certified in more than one specialty please mark all that apply). 
_____ Adult Nurse Practitioner (ANP)  _____ Neonatal Nurse Practitioner 
_____ Family Nurse Practitioner (FNP)  _____ Acute Care Nurse Practitioner 
_____ Pediatric Nurse Practitioner (PNP) _____ Psych Nurse Practitioner 
3.  How many years have your been practicing as a nurse practitioner?  _________   
Knowledge Survey 
1.Which of the following vitamin D substrates is the one most routinely used in serum 
laboratory testing of vitamin D? 
_____  vitamin D hydroxylase 
_____  25-hydroxyvitamin D – 25(OH)D 
_____  1,25-dihydroxyvitamin D1,25(OH) 
_____  previtamin D 
_____ I don’t know 
2.At which of the following thresholds would you consider a patient to be insufficient  of 
vitamin D? 
_____ <60ng/mL 
_____ <50ng/mL 
_____ <40ng/mL 
_____ < 30ng/mL 
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_____ <20ng/mL 
_____ <10ng/mL 
3. At which of the following thresholds would you consider a patient to be deficient of 
vitamin D? 
_____ <60ng/mL 
_____ <50ng/mL 
_____ <40ng/mL 
_____ < 30ng/mL 
_____ <20ng/mL 
_____ <10ng/mL 
4. Is it possible for a patient to have a serum level of vitamin D that is toxic which can 
result in death? 
_____ yes _____ no 
5. The following is a list of potential patients. Please mark (√) your perception of each 
patient’s risk for having decreased serum vitamin D levels. 
 
 
 
Patient description 
High 
Risk for 
low 
vitamin D 
Average 
Risk for 
low 
vitamin D 
Low 
Risk for 
low 
vitamin 
D 
I don’t 
Know 
 
A 55 year old Latino Male who 
works outside riding horses 
 
 
 
_______ 
 
 
_______ 
 
 
_______ 
 
 
_______ 
A Caucasian 3 month old who is 
exclusively breast fed 
 
 
_______ 
 
_______ 
 
_______ 
 
_______ 
An obese 39 year old African 
American female 
 
 
_______ 
 
_______ 
 
_______ 
 
_______ 
A Caucasian 9 year old girl with a 
normal body mass index 
 
 
_______ 
 
_______ 
 
_______ 
 
_______ 
 
A 32 year old Caucasian female 
with a normal BMI who runs 
marathons 
 
_______ 
 
_______ 
 
_______ 
 
_______ 
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A 22 year old Latina female who 
is underweight and works at a  
grocery store  
 
 
_______ 
 
 
_______ 
 
 
_______ 
 
 
______ 
 
A 45 year old Caucasian female 
who is overweight and works a 
desk job 
 
 
 
______ 
 
 
_______ 
 
 
_______ 
 
 
______ 
 
6.The following is a list of patient characteristics. Please mark (√) your perception of 
each characteristic and its relationship to risk of decreased serum vitamin D levels.  
Characteristic   High risk  Average risk Low Risk I don’t 
Know 
Being Underweight  _______ _______ _______ _______ 
Relatively little 
 time in the sun  _______ _______ _______ _______ 
 
Beige skin with brown 
or olive tone – 
Mediterranian/Latino  _______ _______ _______ _______ 
 
Obesity   _______ _______ _______ _______ 
 
White – very fair skin 
tone with freckles  _______ _______ _______ _______ 
 
Dietary intake high  
In fatty fish   _______ _______ _______ _______ 
 
Dark Black Skin  _______ _______ _______ _______  
 
7.If you determine that your patient’s vitamin D level is insufficient (mildly less than 
normal), which of the following are you most likely recommend? (Select all that apply). 
_____ increase intake of foods that contain vitamin D 
_____ increased indoor exercise 
_____ Vitamin D supplementation of 400-1,000 IU daily 
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_____ Vitamin D supplementation of 2,000IU daily 
_____ Vitamin D supplementation of 50,000IU per week 
_____increase sun exposure 
_____ I do not treat vitamin D insufficiency 
_____ I do not currently test for vitamin D insufficiency  
 
8. If you determine that your patient’s vitamin D level is deficient (markedly less than 
normal), which of the following are you most likely recommend? (Select all that apply). 
_____ increase intake of foods that contain vitamin D 
_____ increased indoor exercise 
_____ Vitamin D supplementation of 400-1,000 IU daily 
_____ Vitamin D supplementation of 2,000IU daily 
_____ Vitamin D supplementation of 50,000IU per week 
_____increase sun exposure 
_____ I do not treat vitamin D insufficiency 
_____ I do not currently test for vitamin D insufficiency  
9. The following is a list of foods/activities that contain vitamin D.  Please rank in order 
from number 1 to number 7 the best sources of vitamin D.  (Number 1 being the best 
source and Number 7 being the worst source). 
fortified milk (1 cup)   _____ 
Tuna, canned (3.6oz)   _____ 
Egg yolk -  1   _____ 
Broccoli – 1 cup raw  _____ 
Wild salmon (3.6oz)  _____ 
Exposure to 15 min. 
of sunlight   _____ 
whole grain cereal  –1 cup   _____ 
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10.What is the recommended daily allowance (RDA) of vitamin D  (in international units 
= IU) set by the Food and Drug Administration for individuals 19 -69 years old. 
 
_____  400 IU 
_____  600 IU 
_____  800 IU 
_____  1200 IU 
_____  2000 IU 
 
11. What is the recommended daily allowance (RDA) of vitamin D  (in international 
units = IU) set by the Food and Drug Administration for individuals greater than 70 years 
old. 
 
_____  400 IU 
_____  600 IU 
_____  800 IU 
_____  1200 IU 
_____  2000 IU 
 
12. Which of the following conditions/states so you believe to be associated with low 
serum levels of vitamin D?  (Please select all that apply) 
 
_____  type 2 diabetes   _____ osteomalacia/rickets 
_____  increased risk of falls   _____ muscle/bone pain 
_____  cancer     _____ asthma 
_____ osteoporosis    _____ increased severity/ frequency of 
infections 
_____ depression    _____ autoimmune diseases 
_____ none of the above is associated with low vitamin D 
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13.  The following is a list of resources which can be used to obtain clinical data 
regarding vitamin D. Please mark (√)  the line that correctly indicates how often you have 
used each of the following resources in the last year for clinical information regarding 
vitamin D. 
Resource     Very Often Sometimes Not at all 
Discussion with Colleagues   _______ _______ _______ 
Conference Speaker    _______ _______ _______ 
Internet –Non Journal medical 
Site (Web MD; Mayo clinic)   _______ _______ _______ 
 
Medical Journal Articles  
(ie. New England Journal of Medicine; 
 Lancet; Journal of the American  
Academy of Family Practice  
Physicians)         _______ _______ _______ 
 
Nurse Practitioner targeted  
medical journals (ie. Clinical Advisor;  
Journal of the American Academy  
of Nurse Practitioners).   _______ _______ _______ 
 
 
Internet  - Wikipedia    _______ _______ _______ 
 
Non-Medical Magazine 
 (Ladies Home Journal;  
Good Housekeeping)       _______ _______ _______ 
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